Updated November 2012
Hepatitis is an inflammation, or swelling, of the liver. Alcohol, drugs (including street drugs, over-the-counter medications, and prescription medications), poisons, and several viruses can all cause hepatitis. Viral hepatitis is the term used for any virus that causes inflammation of the liver.
Signs of hepatitis include:
- Jaundice (yellowing of the skin, eyes, and lining of the mouth)
- Dark-colored urine
- Stool that appears pale and clay-like
- Loss of appetite
- General aching
Hepatitis C is a liver disease caused by the hepatitis C virus (HCV). In 2012, The Centers for Disease Control and Prevention (CDC) estimates that there are 3.2 Americans living with chronic (long-lasting) HCV. The World Health Organization estimates that 170 million people are chronically infected with HCV worldwide, including 12 million in India and five to ten million in Europe.
Approximately half of HIV-negative people clear HCV from their bodies without medical treatment within the first six months of becoming infected. For those living with HIV (HIV+), about one in five people will get rid of the virus without treatment. The majority of people do not clear HCV and go on to develop chronic infection.
Chronic HCV may not cause any symptoms for 10 years or more. However, even without symptoms, it can cause serious liver damage leading to cirrhosis (scarring of the liver), liver failure, and death. In fact, HCV is one of the most common causes of liver disease and viral hepatitis is the number one reason for liver transplants in America.
HCV is spread in the following ways:
- Sharing injection needles or 'works'
- Sharing equipment used to snort or smoke drugs (e.g., bills, straws, pipes)
- Sharing needles or inkwells that are used to apply tattoos
- Receiving a transfusion of blood, blood products, or organs before 1992
- Having unprotected sex with someone who has HCV
- Passing the virus from an infected pregnant woman to her baby (less common)
- Sharing personal care items that may come in contact with another person’s blood, such as razors or toothbrushes (less common)
Unfortunately there is still no vaccine to prevent you from being infected with HCV. However, there are vaccines for two other types of hepatitis: A and B. It is strongly recommended that people with HCV get hepatitis A and B vaccinations as early as possible. For more information on hepatitis A and hepatitis B, see our info sheets.
HCV is not commonly passed from a pregnant woman to her baby. The risk of mother-to-child transmission (MTCT) is about five percent. Studies have found that the risk for MTCT of HCV is three to four times higher in women with HIV. There is currently no known treatment that will prevent the transmission of HCV from mother to child.
The best way to prevent HCV infection is to avoid being exposed to blood that is infected with HCV. Do not share equipment to use drugs and make sure tattoo artists use sterile needles and inkwells. Practicing safer sex is also a good idea; you can find tips to protect yourself in our Safer Sex info sheet.
Most people who are infected with HCV do not know it because they have no symptoms. Early signs of HCV can seem like the flu and often go unnoticed. The only way to know for sure if you have HCV is to get a blood test for it.
The CDC recently recommended that everyone born during 1945 through 1965 (the “baby boomers”) get a one-time blood test for HCV. This new recommendation has been released for a number of reasons, including improvements in treatment for hepatitis C and high rates of HCV infection among baby boomers.
Tests for HCV include:
- HCV antibody and viral load
If you have HIV, you should be tested for HCV. The standard HCV test is one that looks for antibodies to HCV in your blood. If your antibody test is positive or if you have risk factors for HCV without a positive antibody test, you should also get an HCV viral load test. The HCV viral load cannot tell if or when someone with HCV will develop liver damage. However, the HCV viral load can help predict how well someone will respond to HCV treatment. Generally, the lower the HCV viral load, the better the chances that treatment will work well.
- Liver enzyme (or liver function) tests
Liver enzyme tests are blood tests that look at levels of liver enzymes. Because levels of liver enzymes can tell us how well the liver is working, liver enzyme tests are often referred to as liver function tests. Liver enzyme tests measure several things that the liver produces, including ALT, AST, bilirubin, albumin, and some indicators of your blood’s ability to clot. Elevated liver enzymes may indicate liver damage. However, some people with HCV have normal liver enzymes, even in very advanced disease.
Worldwide, there are six different types of HCV called genotypes. These genotypes differ in their regional distribution and can predict how well treatment will work. Genotype 1 is the most common globally (60 percent of all infections) and is also the most common in the US. Genotypes 2 and 3 are less common in the US. Genotype 3 is very common in Southeast Asia, while genotype 4 is found mostly in the Middle East and central Africa. Genotype 5 is located almost entirely in South Africa, and genotype 6 is found in Asia.
HCV genotype 1 is less likely to respond to treatment than HCV genotypes 2 and 3. Before you begin treatment, you should have a genotype test to find out which genotype you have. This will help you and your health care provider make decisions about which treatments to use and how long to use them.
- Liver biopsy
A liver biopsy (inserting a needle through the skin and into the liver to obtain a small sample that is examined under a microscope) is the most reliable way to determine how much damage has been done to your liver. It can also help you and your health care provider figure out when to start HCV treatment.
- FibroSURE™ (or FibroTest)
FibroSURE™ is a blood test that looks at six markers of liver activity to measure liver damage. It is often used as a non-invasive alternative to liver biopsy. This test is good at identifying either no liver damage or advanced liver damage. However, if the damage is somewhere between none and advanced, it does not give very helpful information. A liver biopsy gives more detailed information about all levels of liver damage.
FibroScan is a new non-invasive test currently used in Europe but not available in the US. It is similar to an ultrasound, and is done in the office or clinic by your provider. The scan uses a dull probe that presses against the skin over the liver.
Women who are infected with HCV are different from HCV-infected men in a few important ways. First, the good news: women are more likely to clear HCV than men are. This means that when women become infected with HCV, their bodies are more successful at fighting it off. Women who develop chronic HCV infections are also more likely to get rid of HCV with treatment. Lastly, liver disease tends to progress more slowly in women than in men.
However, women with HCV face a few extra challenges compared with HCV-infected men. First, women’s livers are more sensitive to alcohol and are therefore more likely to be damaged by it in smaller amounts. The amount of alcohol women without HCV can drink without damaging their livers is smaller than men’s. For women living with HCV, it is best to avoid alcohol altogether. For HCV-positive women who do drink, however, it is recommended that they not have more than one drink per day.
It is also important for women to know that excess weight can lead to fat in the liver. Fat in the liver increases inflammation and liver damage, and increases the risk of cirrhosis (scarring of the liver) in women living with HCV. Being overweight and having fat in the liver also lowers the chance of being able to get rid of HCV with treatment.
Because both HIV and HCV can be spread by contact with infected blood, many people are infected with both viruses. This is called co-infection. About one in four people living with HIV in the US are co-infected with HCV. Co-infection is even more common among HIV+ injection drug users, of whom about 80 percent also have HCV.
HCV can progress more rapidly and lead to serious liver damage more often in HIV+ people. According to the CDC, having HIV more than triples the risk of liver disease, liver failure, and liver-related death due to HCV. Co-infection with HCV may also make HIV treatment more challenging. Therefore, it is important for HIV+ people to know whether they have HCV. The CDC recommends that all HIV+ people be screened for both hepatitis B and hepatitis C. Some experts recommend that HIV+ people at risk for HCV be screened every year.
Treatment of HIV/HCV co-infection is complicated. It is important to have a health care provider who is familiar with HIV and HCV to get the best treatment for both diseases. The good news is that HCV can be treated successfully, even in HIV+ people.
For more information about HCV treatment, see our Treatment of Hepatitis C info sheet.
Because there is no vaccine for HCV, the best way to avoid getting it is to understand how it is spread and protect yourself through safer sex and using clean needles when injecting. You can also keep your liver healthy by:
- Eating a healthy diet
- Avoiding alcohol and street drugs
- Getting regular physical activity
- Getting vaccinated against hepatitis A and hepatitis B